240 related articles for article (PubMed ID: 12617904)
1. Carbonic anhydrase inhibitors: SAR and X-ray crystallographic study for the interaction of sugar sulfamates/sulfamides with isozymes I, II and IV.
Casini A; Antel J; Abbate F; Scozzafava A; David S; Waldeck H; Schäfer S; Supuran CT
Bioorg Med Chem Lett; 2003 Mar; 13(5):841-5. PubMed ID: 12617904
[TBL] [Abstract][Full Text] [Related]
2. Carbonic anhydrase inhibitors: anticonvulsant sulfonamides incorporating valproyl and other lipophilic moieties.
Masereel B; Rolin S; Abbate F; Scozzafava A; Supuran CT
J Med Chem; 2002 Jan; 45(2):312-20. PubMed ID: 11784136
[TBL] [Abstract][Full Text] [Related]
3. Carbonic anhydrase inhibitors. Inhibition of the membrane-bound human and bovine isozymes IV with sulfonamides.
Innocenti A; Firnges MA; Antel J; Wurl M; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2005 Feb; 15(4):1149-54. PubMed ID: 15686931
[TBL] [Abstract][Full Text] [Related]
4. Carbonic anhydrase inhibitors: aliphatic N-phosphorylated sulfamates--a novel zinc-anchoring group leading to nanomolar inhibitors.
Bonnac L; Innocenti A; Winum JY; Casini A; Montero JL; Scozzafava A; Barragan V; Supuran CT
J Enzyme Inhib Med Chem; 2004 Jun; 19(3):275-8. PubMed ID: 15500000
[TBL] [Abstract][Full Text] [Related]
5. Carbonic anhydrase inhibition. Insight into the characteristics of zonisamide, topiramate, and the sulfamide cognate of topiramate.
Shank RP; Smith-Swintosky VL; Maryanoff BE
J Enzyme Inhib Med Chem; 2008 Apr; 23(2):271-6. PubMed ID: 18343915
[TBL] [Abstract][Full Text] [Related]
6. Carbonic anhydrase inhibitors: inhibition of cytosolic isozymes I and II with sulfamide derivatives.
Casini A; Winum JY; Montero JL; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2003 Mar; 13(5):837-40. PubMed ID: 12617903
[TBL] [Abstract][Full Text] [Related]
7. Comparison of sulfamate and sulfamide groups for the inhibition of carbonic anhydrase-II by using topiramate as a structural platform.
Maryanoff BE; McComsey DF; Costanzo MJ; Hochman C; Smith-Swintosky V; Shank RP
J Med Chem; 2005 Mar; 48(6):1941-7. PubMed ID: 15771438
[TBL] [Abstract][Full Text] [Related]
8. Carbonic anhydrase inhibitors: E7070, a sulfonamide anticancer agent, potently inhibits cytosolic isozymes I and II, and transmembrane, tumor-associated isozyme IX.
Abbate F; Casini A; Owa T; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2004 Jan; 14(1):217-23. PubMed ID: 14684331
[TBL] [Abstract][Full Text] [Related]
9. Carbonic anhydrase inhibitors: inhibition of the transmembrane isozyme XIV with sulfonamides.
Nishimori I; Vullo D; Innocenti A; Scozzafava A; Mastrolorenzo A; Supuran CT
Bioorg Med Chem Lett; 2005 Sep; 15(17):3828-33. PubMed ID: 16039848
[TBL] [Abstract][Full Text] [Related]
10. QSAR studies of sulfamate and sulfamide inhibitors targeting human carbonic anhydrase isozymes I, II, IX and XII.
Tarko L; Supuran CT
Bioorg Med Chem; 2013 Mar; 21(6):1404-9. PubMed ID: 23206986
[TBL] [Abstract][Full Text] [Related]
11. Carbonic anhydrase inhibitors. Comparison of aliphatic sulfamate/bis-sulfamate adducts with isozymes II and IX as a platform for designing tight-binding, more isoform-selective inhibitors.
Vitale RM; Alterio V; Innocenti A; Winum JY; Monti SM; De Simone G; Supuran CT
J Med Chem; 2009 Oct; 52(19):5990-8. PubMed ID: 19731956
[TBL] [Abstract][Full Text] [Related]
12. Carbonic anhydrase inhibitors: clash with Ala65 as a means for designing inhibitors with low affinity for the ubiquitous isozyme II, exemplified by the crystal structure of the topiramate sulfamide analogue.
Winum JY; Temperini C; El Cheikh K; Innocenti A; Vullo D; Ciattini S; Montero JL; Scozzafava A; Supuran CT
J Med Chem; 2006 Nov; 49(24):7024-31. PubMed ID: 17125255
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of novel pyrazoline-based aromatic sulfamates with potent carbonic anhydrase isoforms II, IV and IX inhibitory efficacy.
Nocentini A; Moi D; Balboni G; Salvadori S; Onnis V; Supuran CT
Bioorg Chem; 2018 Apr; 77():633-639. PubMed ID: 29502024
[TBL] [Abstract][Full Text] [Related]
14. In vitro inhibition of α-carbonic anhydrase isozymes by some phenolic compounds.
Oztürk Sarikaya SB; Topal F; Sentürk M; Gülçin I; Supuran CT
Bioorg Med Chem Lett; 2011 Jul; 21(14):4259-62. PubMed ID: 21669522
[TBL] [Abstract][Full Text] [Related]
15. Discovery of thiazolin-4-one-based aromatic sulfamates as a new class of carbonic anhydrase isoforms I, II, IV, and IX inhibitors.
Nocentini A; Moi D; Balboni G; Onnis V; Supuran CT
Bioorg Chem; 2018 Apr; 77():293-299. PubMed ID: 29421705
[TBL] [Abstract][Full Text] [Related]
16. The first example of a significant active site conformational rearrangement in a carbonic anhydrase-inhibitor adduct: the carbonic anhydrase I-topiramate complex.
Alterio V; Monti SM; Truppo E; Pedone C; Supuran CT; De Simone G
Org Biomol Chem; 2010 Aug; 8(15):3528-33. PubMed ID: 20505865
[TBL] [Abstract][Full Text] [Related]
17. 5-Substituted-(1,2,3-triazol-4-yl)thiophene-2-sulfonamides strongly inhibit human carbonic anhydrases I, II, IX and XII: solution and X-ray crystallographic studies.
Leitans J; Sprudza A; Tanc M; Vozny I; Zalubovskis R; Tars K; Supuran CT
Bioorg Med Chem; 2013 Sep; 21(17):5130-8. PubMed ID: 23859774
[TBL] [Abstract][Full Text] [Related]
18. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with N-hydroxysulfamides--a new zinc-binding function in the design of inhibitors.
Winum JY; Innocenti A; Nasr J; Montero JL; Scozzafava A; Vullo D; Supuran CT
Bioorg Med Chem Lett; 2005 May; 15(9):2353-8. PubMed ID: 15837324
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and docking studies of new 1,3,4-thiadiazole-2-thione derivatives with carbonic anhydrase inhibitory activity.
Abdel-Hamid MK; Abdel-Hafez AA; El-Koussi NA; Mahfouz NM; Innocenti A; Supuran CT
Bioorg Med Chem; 2007 Nov; 15(22):6975-84. PubMed ID: 17822907
[TBL] [Abstract][Full Text] [Related]
20. Examination of two independent kinetic assays for determining the inhibition of carbonic anhydrases I and II: structure-activity comparison of sulfamates and sulfamides.
Shank RP; McComsey DF; Smith-Swintosky VL; Maryanoff BE
Chem Biol Drug Des; 2006 Aug; 68(2):113-9. PubMed ID: 16999776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
